
Yahoo · 15 de oct de 2026
Johnson & Johnson (JNJ) stock trades at 29.1 times its earnings over the past twelve months, compared with 22.7 for the S&P 500. Investors paying that premium a…
Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Últimos 224 días · 12/11/25 — 14/10/26
+43.14%
Precio
$ 27.700
Var. %
+1,31%
Volumen operado
9.009
Precio JNJ
US$ 256,08
Teórico (precio / ratio)
JNJ ÷ 15
US$ 17,07
Sí, existe el CEDEAR de JNJ (Johnson & Johnson) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es JNJ.
El ticker del CEDEAR de Johnson & Johnson en Argentina es JNJ. La acción subyacente cotiza en NYSE con el símbolo JNJ.
El CEDEAR JNJ tiene un ratio de 15:1. Eso significa que 15 CEDEARs equivalen a 1 acción de JNJ.
El CEDEAR JNJ cotiza hoy a $ 27.700 en pesos argentinos, con una variación diaria de +1,31%.

Yahoo · 15 de oct de 2026
Johnson & Johnson (JNJ) stock trades at 29.1 times its earnings over the past twelve months, compared with 22.7 for the S&P 500. Investors paying that premium a…

Yahoo · 15 de oct de 2026
Over the past month, shares of Liquidia (LQDA) have lost 59%, even as the S&P 500 gained 2.5%. Reuters reported that the stock dropped nearly 50% on September 3…

Yahoo · 14 de oct de 2026
Boston Scientific (BSX) stock currently trades at 17.2 times earnings. This compares to an average multiple of 55.9 over the last twelve quarter-ends, excluding…
Precio de cierre en pesos argentinos. Fuente: data912.
Cotización
US$ 18,05
vs teórico
+5,73%
Cotización MEP implícita
$ 1.534,63
Cotización
US$ 16,96
vs teórico
-0,66%
Cotización Cable implícita
$ 1.633,25
La acción subyacente JNJ (Johnson & Johnson) cotiza a US$ 256,08 en su mercado de origen (NYSE).
El precio teórico del CEDEAR JNJ se calcula dividiendo el precio de JNJ por el ratio (15). Hoy resulta en US$ 17,07.
En BYMA podés operar JNJ en pesos, JNJD en dólar MEP y JNJC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR JNJ en pesos argentinos, con datos de data912.

ChartMill · 14 de oct de 2026
Uncover the latest developments among dow jones stocks in today's session. Stay tuned to the dow jones index's top gainers and losers on Wednesday.

Yahoo · 14 de oct de 2026
The pharma company is on track to reach $100 billion in recorded revenue despite “temporary” headwinds in its medtech segment, executives said.

SeekingAlpha · 14 de oct de 2026
JNJ Q3 2026 earnings look strong, but deeper analysis shows declining shareholder earnings. Click for more on JNJ stock.
Benzinga · 14 de oct de 2026
Leerink Partners analyst David Risinger maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $276 to $272.

ChartMill · 14 de oct de 2026
Curious about the top performers within the dow jones index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and loser…
Noticias vía Finnhub